Vertex is expanding beyond its cystic fibrosis franchise.
Amgen (NASDAQ: AMGN) today announced the appointment of David W. Gibbs to its Board of Directors, effective immediately.
Tempus AI delivers robust 22% YoY revenue growth, forecasting $1.6bn in 2026 and demonstrating strong commercial traction.
Published data validates ZIP12-mediated zinc signaling as a novel driver of pulmonary vascular remodeling and supports a differentiated ...
An observational study of 20 pudu deer from three Chilean provinces found that greater native-forest fragmentation was ...
Hello! I'm Nao, and I attend Carol Davila University of Medicine and Pharmacy in Romania 🇷🇴In the previous article, I ...
Recursion to Host Webinar Focused on Updated REC-4881 (FAP) Data from CGA-IGC on Tuesday, November 3
A third quarter recap from Najat Khan, Ph.D., Chief Executive Officer and President of Recursion, including encouraging REC-1245 monotherapy data, as well as a presentation REC-4481 data from the ...
What if a weapon against some of the world’s most stubborn bacteria were hiding in the soil beneath our feet? Could these ...
A 2026 narrative review links inherited HLA class I and class II variation to pediatric neuroblastoma susceptibility and selected outcomes, while finding that most associations remain unreplicated and ...
Time to read: 15 minutesTeaching English to a child who can barely speak yet. Drilling letters and numbers with flashcards.
Leukemia in the Atomic Age / Acute Lymphoblastic Leukemia, ALL, cancer, Hematology, OncoDaily, OncoDailyBlood, Oncology, ...
The Amgen Foundation today announced a new $13.4 million commitment to the Amgen Biotech Experience (ABE), a global educ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results